In the current study, we demonstrated for the first time that VIP/VIPR1 signaling regulated the expression of several arginine/UC key enzymes in HCC, such as ASS1, CPS1, ASL, and ARG1/2. Alterations of these genes may contribute to HCC progression by dysregulating arginine metabolism. Here, VIP is linked to hepatocellular carcinoma.